SELENBP1 and colorectal carcinoma: To confirm whether SELENBP1 suppress CRC tumorigenesis in vivo, we inoculated HCT-15 cells that stably overexpressed SELENBP1 or the control subcutaneously into the flanks of nude mice (n = 5/group).